Prestige Consumer Healthcare
PBH
#4654
Rank
ยฃ1.72 B
Marketcap
ยฃ36.46
Share price
0.75%
Change (1 day)
-21.37%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): ยฃ2.69

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is ยฃ2.71. In 2025 the company made an earnings per share (EPS) of ยฃ2.88 a decrease over its 2024 EPS that were of ยฃ3.25.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ2.69-6.65%
2025ยฃ2.88-11.4%
2024ยฃ3.25-367.08%
2023-ยฃ1.22-138.33%
2022ยฃ3.1811.7%
2021ยฃ2.8413.6%
2020ยฃ2.50-651.67%
2019-ยฃ0.45-148.78%
2018ยฃ0.93-83.29%
2017ยฃ5.56437.23%
2016ยฃ1.04-34.13%
2015ยฃ1.5752.94%
2014ยฃ1.03-8.11%
2013ยฃ1.12
2011ยฃ0.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ6.60 143.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
ยฃ5.11 88.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.03 85.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ0.57-78.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ2.36-13.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
ยฃ4.67 72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
ยฃ1.75-35.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ2.42-10.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-ยฃ22.39-925.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
ยฃ0.92-66.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel